# GCT Semiconductor Holding, Inc.: financial statements, quarterly

GCTS · NYSE · CIK 1851961 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gcts.md) · [Financials](/companies/gcts/financials.md) · [Filings](/companies/gcts/filings.md) · [Insiders](/companies/gcts/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gcts/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4.5](/filings/0000950170-24-127082.md) | [4.2 d](/filings/0000950170-25-044438.md) | [3.3](/filings/0000950170-25-071424.md) | [1.5](/filings/0001851961-25-000010.md) | [2.6](/filings/0001193125-25-277777.md) | [1.8 d](/filings/0001193125-26-124183.md) | [0.5](/filings/0001193125-26-219536.md) | [1.2](/filings/0001193125-26-342564.md) | [0.4](/filings/0001193125-25-277777.md) | [0.8 d](/filings/0001193125-26-124183.md) | [1.9](/filings/0001193125-26-219536.md) | [1.0](/filings/0001193125-26-342564.md) |
| Cost of revenue | $m | [3.9](/filings/0000950170-24-127082.md) | [2.3 d](/filings/0000950170-25-044438.md) | [1.3](/filings/0000950170-25-071424.md) | [0.5](/filings/0001851961-25-000010.md) | [1.0](/filings/0001193125-25-277777.md) | [1.2 d](/filings/0001193125-26-124183.md) | [0.4](/filings/0001193125-26-219536.md) | [0.8](/filings/0001193125-26-342564.md) | [1.5](/filings/0001193125-25-277777.md) | [2.0 d](/filings/0001193125-26-124183.md) | [1.0](/filings/0001193125-26-219536.md) | [1.2](/filings/0001193125-26-342564.md) |
| Gross profit | $m | [0.5](/filings/0000950170-24-127082.md) | [1.9 d](/filings/0000950170-25-044438.md) | [2.0](/filings/0000950170-25-071424.md) | [0.9](/filings/0001851961-25-000010.md) | [1.6](/filings/0001193125-25-277777.md) | [0.6 d](/filings/0001193125-26-124183.md) | [0.1](/filings/0001193125-26-219536.md) | [0.4](/filings/0001193125-26-342564.md) | [(1.1)](/filings/0001193125-25-277777.md) | [(1.2) d](/filings/0001193125-26-124183.md) | [0.9](/filings/0001193125-26-219536.md) | [(0.2)](/filings/0001193125-26-342564.md) |
| Research and development | $m | [2.4](/filings/0000950170-24-127082.md) | [3.5 d](/filings/0000950170-25-044438.md) | [5.5](/filings/0000950170-25-071424.md) | [4.2](/filings/0001851961-25-000010.md) | [4.2](/filings/0001193125-25-277777.md) | [3.4 d](/filings/0001193125-26-124183.md) | [4.1](/filings/0001193125-26-219536.md) | [3.5](/filings/0001193125-26-342564.md) | [3.3](/filings/0001193125-25-277777.md) | [3.1 d](/filings/0001193125-26-124183.md) | [3.2](/filings/0001193125-26-219536.md) | [3.3](/filings/0001193125-26-342564.md) |
| Operating income | $m | [(4.0)](/filings/0000950170-24-127082.md) | [(4.3) d](/filings/0000950170-25-044438.md) | [7.2](/filings/0000950170-25-071424.md) | [(7.1)](/filings/0001851961-25-000010.md) | [(5.9)](/filings/0001193125-25-277777.md) | [(7.4) d](/filings/0001193125-26-124183.md) | [(7.7)](/filings/0001193125-26-219536.md) | [(7.6)](/filings/0001193125-26-342564.md) | [(9.3)](/filings/0001193125-25-277777.md) | [(12.0) d](/filings/0001193125-26-124183.md) | [(6.1)](/filings/0001193125-26-219536.md) | [(7.4)](/filings/0001193125-26-342564.md) |
| Interest expense | $m | [1.2](/filings/0000950170-24-127082.md) | [1.4 d](/filings/0000950170-25-044438.md) | [2.1](/filings/0000950170-25-071424.md) | [0.8](/filings/0001851961-25-000010.md) | [0.7](/filings/0001193125-25-277777.md) | [0.4 d](/filings/0001193125-26-124183.md) | [1.1](/filings/0001193125-26-219536.md) | [1.5](/filings/0001193125-26-342564.md) | [1.8](/filings/0001193125-25-277777.md) | [1.6 d](/filings/0001193125-26-124183.md) | [1.8](/filings/0001193125-26-219536.md) | [1.2](/filings/0001193125-26-342564.md) |
| Income tax | $m | [0.0](/filings/0000950170-24-127082.md) | [0.4 d](/filings/0000950170-25-044438.md) | [0.1](/filings/0000950170-25-071424.md) | [0.1](/filings/0001851961-25-000010.md) | [0.1](/filings/0001193125-25-277777.md) | [0.3 d](/filings/0001193125-26-124183.md) | [0.1](/filings/0001193125-26-219536.md) | [0.0](/filings/0001193125-26-342564.md) | [0.2](/filings/0001193125-25-277777.md) | [0.6 d](/filings/0001193125-26-124183.md) | [0.1](/filings/0001193125-26-219536.md) | [0.1](/filings/0001193125-26-342564.md) |
| Net income | $m | [(4.3)](/filings/0000950170-24-127082.md) | [(10.2) d](/filings/0000950170-25-044438.md) | [0.8](/filings/0001193125-25-277777.md) | [(1.0)](/filings/0001193125-25-277777.md) | [(7.1)](/filings/0001193125-25-277777.md) | [(5.0) d](/filings/0001193125-26-124183.md) | [(7.0)](/filings/0001193125-26-342564.md) | [(13.5)](/filings/0001193125-26-342564.md) | [(13.8)](/filings/0001193125-25-277777.md) | [(9.0) d](/filings/0001193125-26-124183.md) | [(9.9)](/filings/0001193125-26-342564.md) | [(20.4)](/filings/0001193125-26-342564.md) |
| Diluted EPS | $ per share | [(0.18)](/filings/0000950170-24-127082.md) | not reported | [0.03](/filings/0000950170-25-071424.md) | [(0.02)](/filings/0001851961-25-000010.md) | [(0.16)](/filings/0001193125-25-277777.md) | not reported | [(0.15)](/filings/0001193125-26-219536.md) | [(0.26)](/filings/0001193125-26-342564.md) | [(0.25)](/filings/0001193125-25-277777.md) | not reported | [(0.15)](/filings/0001193125-26-219536.md) | [(0.25)](/filings/0001193125-26-342564.md) |
| Basic EPS | $ per share | [(0.18)](/filings/0000950170-24-127082.md) | not reported | [0.03](/filings/0000950170-25-071424.md) | [(0.02)](/filings/0001851961-25-000010.md) | [(0.16)](/filings/0001193125-25-277777.md) | not reported | [(0.15)](/filings/0001193125-26-219536.md) | [(0.26)](/filings/0001193125-26-342564.md) | [(0.25)](/filings/0001193125-25-277777.md) | not reported | [(0.15)](/filings/0001193125-26-219536.md) | [(0.25)](/filings/0001193125-26-342564.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.2](/filings/0001410578-23-002439.md) | [0.3](/filings/0000950170-25-044438.md) | [16.1](/filings/0001410578-24-000825.md) | [4.0](/filings/0001410578-24-001463.md) | [1.8](/filings/0000950170-24-127082.md) | [1.4](/filings/0001193125-26-124183.md) | [1.0](/filings/0000950170-25-071424.md) | [1.3](/filings/0001851961-25-000010.md) | [8.3](/filings/0001193125-25-277777.md) | [0.6](/filings/0001193125-26-342564.md) | [7.2](/filings/0001193125-26-219536.md) | [30.2](/filings/0001193125-26-342564.md) |
| Current assets | $m | [0.3](/filings/0001410578-23-002439.md) | [13.0](/filings/0000950170-25-044438.md) | [32.8](/filings/0001410578-24-000825.md) | [20.6](/filings/0001410578-24-001463.md) | [20.0](/filings/0000950170-24-127082.md) | [17.6](/filings/0001193125-26-124183.md) | [15.4](/filings/0000950170-25-071424.md) | [15.7](/filings/0001851961-25-000010.md) | [21.9](/filings/0001193125-25-277777.md) | [11.9](/filings/0001193125-26-342564.md) | [19.0](/filings/0001193125-26-219536.md) | [46.7](/filings/0001193125-26-342564.md) |
| Total assets | $m | [43.4](/filings/0001410578-23-002439.md) | [16.4](/filings/0000950170-25-044438.md) | [35.8](/filings/0001410578-24-000825.md) | [23.4](/filings/0001410578-24-001463.md) | [22.6](/filings/0000950170-24-127082.md) | [19.9](/filings/0001193125-26-124183.md) | [17.5](/filings/0000950170-25-071424.md) | [17.6](/filings/0001851961-25-000010.md) | [24.3](/filings/0001193125-25-277777.md) | [15.6](/filings/0001193125-26-342564.md) | [22.4](/filings/0001193125-26-219536.md) | [49.8](/filings/0001193125-26-342564.md) |
| Current liabilities | $m | [6.3](/filings/0001410578-23-002439.md) | [115](/filings/0000950170-25-044438.md) | [72.6](/filings/0001410578-24-000825.md) | [62.9](/filings/0001410578-24-001463.md) | [61.9](/filings/0000950170-24-127082.md) | [60.9](/filings/0001193125-26-124183.md) | [71.4](/filings/0000950170-25-071424.md) | [74.0](/filings/0001851961-25-000010.md) | [87.1](/filings/0001193125-25-277777.md) | [79.6](/filings/0001193125-26-342564.md) | [74.5](/filings/0001193125-26-219536.md) | [56.7](/filings/0001193125-26-342564.md) |
| Total liabilities | $m | [21.7](/filings/0001410578-23-002439.md) | [132](/filings/0000950170-25-044438.md) | [98.2](/filings/0001410578-24-000825.md) | [81.7](/filings/0001410578-24-001463.md) | [80.9](/filings/0000950170-24-127082.md) | [79.2](/filings/0001193125-26-124183.md) | [83.1](/filings/0000950170-25-071424.md) | [87.6](/filings/0001851961-25-000010.md) | [104](/filings/0001193125-25-277777.md) | [98.9](/filings/0001193125-26-342564.md) | [96.3](/filings/0001193125-26-219536.md) | [102](/filings/0001193125-26-342564.md) |
| Long-term debt | $m | not reported | [6.2](/filings/0000950170-25-044438.md) | [4.7](/filings/0001410578-24-000825.md) | [4.7](/filings/0001410578-24-001463.md) | [4.8](/filings/0000950170-24-127082.md) | [4.9](/filings/0001193125-26-124183.md) | [0.0](/filings/0000950170-25-071424.md) | [0.0](/filings/0001851961-25-000010.md) | [0.0](/filings/0001193125-25-277777.md) | [6.0](/filings/0001193125-26-124183.md) | [57.7](/filings/0001193125-26-219536.md) | [55.1](/filings/0001193125-26-342564.md) |
| Current portion of debt | $m | not reported | [72.3](/filings/0000950170-25-044438.md) | [45.5](/filings/0001410578-24-000825.md) | [38.6](/filings/0001410578-24-001463.md) | [36.8](/filings/0000950170-24-127082.md) | [37.6](/filings/0001193125-26-124183.md) | [50.2](/filings/0000950170-25-071424.md) | [51.8](/filings/0001851961-25-000010.md) | [64.7](/filings/0001193125-25-277777.md) | [56.6](/filings/0001193125-26-124183.md) | not reported | not reported |
| Shareholders' equity | $m | [(106)](/filings/0000950170-24-127082.md) | [(115)](/filings/0001193125-26-124183.md) | [(62.4)](/filings/0001193125-25-277777.md) | [(58.3)](/filings/0001193125-25-277777.md) | [(58.3)](/filings/0001193125-25-277777.md) | [(59.3)](/filings/0001193125-26-342564.md) | [(65.6)](/filings/0001193125-26-342564.md) | [(70.0)](/filings/0001193125-26-342564.md) | [(80.1)](/filings/0001193125-25-277777.md) | [(83.3)](/filings/0001193125-26-342564.md) | [(73.9)](/filings/0001193125-26-342564.md) | [(52.0)](/filings/0001193125-26-342564.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(1.5) d](/filings/0000950170-24-127082.md) | [(0.9) d](/filings/0000950170-25-044438.md) | [(14.4)](/filings/0000950170-25-071424.md) | [(9.6) d](/filings/0001851961-25-000010.md) | [(4.6) d](/filings/0001193125-25-277777.md) | [(2.3) d](/filings/0001193125-26-124183.md) | [(8.0)](/filings/0001193125-26-219536.md) | [(8.6) d](/filings/0001193125-26-342564.md) | [(6.9) d](/filings/0001193125-25-277777.md) | [(7.2) d](/filings/0001193125-26-124183.md) | [(7.4)](/filings/0001193125-26-219536.md) | [(16.6) d](/filings/0001193125-26-342564.md) |
| Capital expenditure | $m | [0.1 d](/filings/0000950170-24-127082.md) | [0.0 d](/filings/0000950170-25-044438.md) | not reported | not reported | [0.1 d](/filings/0001193125-25-277777.md) | [0.4 d](/filings/0001193125-26-124183.md) | [0.1](/filings/0001193125-26-219536.md) | [0.1 d](/filings/0001193125-26-342564.md) | [0.9 d](/filings/0001193125-25-277777.md) | [1.3 d](/filings/0001193125-26-124183.md) | [0.1](/filings/0001193125-26-219536.md) | [0.3 d](/filings/0001193125-26-342564.md) |
| Share repurchases | $m | [0.0 d](/filings/0001410578-23-002439.md) | [1.1 d](/filings/0001410578-24-000166.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2021-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [7.5](/filings/0001410578-21-000544.md) | [23.9](/filings/0001410578-24-000825.md) | [23.9](/filings/0001410578-24-001463.md) | [24.1](/filings/0000950170-24-127082.md) | [26.3](/filings/0000950170-25-071424.md) | [44.1](/filings/0001851961-25-000010.md) | [45.6](/filings/0001193125-25-277777.md) | [47.6](/filings/0001193125-26-219536.md) | [51.7](/filings/0001193125-26-342564.md) | [55.5](/filings/0001193125-25-277777.md) | [66.1](/filings/0001193125-26-219536.md) | [82.6](/filings/0001193125-26-342564.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 91,969,726 at 2026-08-06, from the cover of the [10-Q filed 2026-08-10](/filings/0001193125-26-342564.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.